Predicitive factors for nonresponse in genotype 2/3 infected chronic hepatitis c (CHC) patients treated with peginterferon alfa-2a (PEG) and ribavirin (RBV) in real life setting

This article has no abstract
Epistemonikos ID: ce720048a8a1cce7b5b1e0e63144e6d3e5855345
First added on: Feb 05, 2025